Neurological manifestations in COVID-19 caused by SARS-CoV-2

CNS Neuroscience and Therapeutics

Volumn 26, Issue 5, 2020, Pages 499-501

  Baig, Abdul Mannan ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ANOSMIA; ATAXIA; BRAIN EDEMA; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID ANALYSIS; CONVULSION; CORONAVIRUS DISEASE 2019; CORONAVIRUS INFECTION; HUMAN; HYPOGEUSIA; MENINGOENCEPHALITIS; NERVE CELL DEGENERATION; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NONHUMAN; NOTE; PANDEMIC; SARS-RELATED CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VASCULAR ENDOTHELIUM; BETACORONAVIRUS; BRAIN; ISOLATION AND PURIFICATION; LABORATORY TECHNIQUE; PATHOPHYSIOLOGY; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIROLOGY; VIRUS PNEUMONIA;

BETACORONAVIRUS; BRAIN; CLINICAL LABORATORY TECHNIQUES; CORONAVIRUS INFECTIONS; HUMANS; NERVOUS SYSTEM DISEASES; PANDEMICS; PNEUMONIA, VIRAL; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 85083280053     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.13372     Document Type: Note

References (11)

1. Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients. J Med Virol. 2020. https://doi.org/10.1002/jmv.25728 [Epub ahead of print] Review.
2. Mao L, Wang M, Chen S, et al. Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study. medRxiv. https://doi.org/10.1101/2020.02.22.20026500
3. The World Health Organization (WHO) The First Few X (FFX) Cases and contact investigation protocol for 2019-novel coronavirus (2019-nCoV) infection. WHO REFERENCE NUMBER: WHO/2019-nCoV/FFXprotocol/2020.2 CC BY-NC-SA 3.0 IGO; 29 January 2020 | Publication.
4. Xu J, Zhong S, Liu J, et al. Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis. Clin Infect Dis. 2005;41:1089-1096.
5. Lau K, Yu W, Chu C, Lau S, Sheng B, Yuen K. Possible central nervous system infection by SARS coronavirus. Emerg Infect Dis. 2004;10(2):342-344.
6. Gu J, Korteweg C. Pathology and pathogenesis of severe acute respiratory syndrome. Am J Pathol. 2007;170(4):1136-1147.
7. Baig AM, Khan NA. Novel chemotherapeutic strategies in the management of primary amoebic meningoencephalitis due to Naegleria fowleri. CNS Neurosci Ther. 2014;20(3):289-290.
8. Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008;82(15):7264-7275.
9. Zhou L, Zhang M, Gao J, Wang J. Sars-Cov-2: Underestimated damage to nervous system [published online ahead of print, 2020 Mar 24]. Travel Med Infect Dis. 2020; https://doi.org/10.1016/j.tmaid.2020.101642
10. Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features [published online ahead of print, 2020 Mar 31]. Radiology. 2020; https://doi.org/10.1148/radiol.2020201187
11. ANOSMIA: NEW! COVID-19 ANOSMIA REPORTING TOOL OPEN TO ALL CLINICIANS, American Academy of Otolaryngology- Head and Neck Surgery https://www.entnet.org/content/coronavirus-disease-2019-resources Accessed April 1, 2020.